G M Clifford

Summary

Affiliation: International Agency for Research on Cancer
Country: France

Publications

  1. pmc Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection
    G M Clifford
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Br J Cancer 106:447-52. 2012
  2. pmc Human papillomavirus type 16 E6 variants in France and risk of viral persistence
    Iris Cornet
    International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon, 69372 Cedex 08, France
    Infect Agent Cancer 8:4. 2013
  3. pmc Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
    Beatriz Serrano
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL, Institut CatalĂ  d Oncologia ICO Catalan Institute of Oncology, Gran Via de L Hospitalet, 199 203, L Hospitalet de Llobregat, Barcelona, Spain
    Infect Agent Cancer 7:38. 2012
  4. pmc Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
    Mark Schiffman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, 20892, USA
    Infect Agent Cancer 4:8. 2009
  5. doi request reprint Cancer risk in HIV-infected persons: influence of CD4(+) count
    Gary M Clifford
    International Agency for Research on Cancer, Lyon Cedex 08, France
    Future Oncol 5:669-78. 2009
  6. doi request reprint Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
    Gary M Clifford
    International Agency for Research on Cancer, Lyon, France
    AIDS 22:2135-41. 2008
  7. pmc Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria
    Clement Okolo
    International Agency for Research on Cancer, Lyon, France
    Infect Agent Cancer 5:24. 2010
  8. ncbi request reprint Human papillomavirus types among women infected with HIV: a meta-analysis
    Gary M Clifford
    International Agency for Research on Cancer, Lyon, France
    AIDS 20:2337-44. 2006
  9. doi request reprint Hodgkin lymphoma in the Swiss HIV Cohort Study
    Gary M Clifford
    International Agency for Research on Cancer, Lyon, France
    Blood 113:5737-42. 2009
  10. ncbi request reprint Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
    Gary Clifford
    International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon Cedex 08, France
    Vaccine 24:S3/26-34. 2006

Detail Information

Publications39

  1. pmc Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection
    G M Clifford
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Br J Cancer 106:447-52. 2012
    ..Immunodeficiency and AIDS-related pulmonary infections have been suggested as independent causes of lung cancer among HIV-infected persons, in addition to smoking...
  2. pmc Human papillomavirus type 16 E6 variants in France and risk of viral persistence
    Iris Cornet
    International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon, 69372 Cedex 08, France
    Infect Agent Cancer 8:4. 2013
    ..abstract:..
  3. pmc Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
    Beatriz Serrano
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL, Institut CatalĂ  d Oncologia ICO Catalan Institute of Oncology, Gran Via de L Hospitalet, 199 203, L Hospitalet de Llobregat, Barcelona, Spain
    Infect Agent Cancer 7:38. 2012
    ..abstract:..
  4. pmc Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
    Mark Schiffman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, 20892, USA
    Infect Agent Cancer 4:8. 2009
    ..This article describes for open discussion an approach recently taken by a World Health Organization International Agency for Research on Cancer (IARC) Monographs Working Group to re-assess the carcinogenicity of different HPV types...
  5. doi request reprint Cancer risk in HIV-infected persons: influence of CD4(+) count
    Gary M Clifford
    International Agency for Research on Cancer, Lyon Cedex 08, France
    Future Oncol 5:669-78. 2009
    ....
  6. doi request reprint Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
    Gary M Clifford
    International Agency for Research on Cancer, Lyon, France
    AIDS 22:2135-41. 2008
    ..To investigate HIV-related immunodeficiency as a risk factor for hepatocellular carcinoma (HCC) among persons infected with HIV, while controlling for the effect of frequent coinfection with hepatitis C and B viruses...
  7. pmc Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria
    Clement Okolo
    International Agency for Research on Cancer, Lyon, France
    Infect Agent Cancer 5:24. 2010
    ..Concerns have been raised that the proportion of cervical cancer preventable by human papillomavirus (HPV) 16/18 vaccines might be lower in sub-Saharan Africa than elsewhere...
  8. ncbi request reprint Human papillomavirus types among women infected with HIV: a meta-analysis
    Gary M Clifford
    International Agency for Research on Cancer, Lyon, France
    AIDS 20:2337-44. 2006
    ..It is not known to what extent these different types are associated with high-grade squamous intraepithelial lesions (HSIL) and cancer...
  9. doi request reprint Hodgkin lymphoma in the Swiss HIV Cohort Study
    Gary M Clifford
    International Agency for Research on Cancer, Lyon, France
    Blood 113:5737-42. 2009
    ..In conclusion, HL risk does not appear to be increasing in recent years or among PHIV using cART in Switzerland, and there was no evidence that HL risk should be increased in the setting of improved immunity...
  10. ncbi request reprint Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
    Gary Clifford
    International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon Cedex 08, France
    Vaccine 24:S3/26-34. 2006
    ..After HPV-16/18, the six most common HPV types are the same in all world regions, namely 31, 33, 35, 45, 52 and 58; these account for an additional 20% of cervical cancers worldwide...
  11. ncbi request reprint Immunity, infection, and cancer
    Gary Clifford
    International Agency for Research on Cancer, 69372 Lyon Cedex 08, France
    Lancet 370:6-7. 2007
  12. ncbi request reprint Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis
    G M Clifford
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Lancet 366:991-8. 2005
    ..We aimed to compare HPV-type distribution in representative samples of women from different world regions...
  13. pmc Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
    G M Clifford
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150, cours Albert Thomas, 69008, Lyon, France
    Br J Cancer 89:101-5. 2003
    ..These data suggest that HSILs infected with HPV16, 18 and 45 preferentially progress to SCC. This may have implications for follow-up protocols of future HPV-based cervical cancer screening programmes and for HPV vaccine trials...
  14. ncbi request reprint Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer
    Gary M Clifford
    IARC, 150 cours Albert Thomas, F 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 14:1157-64. 2005
    ..Some regional differences in the relative importance of HPV genotypes in LSIL were noted...
  15. ncbi request reprint Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy
    Gary M Clifford
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    J Natl Cancer Inst 97:425-32. 2005
    ....
  16. pmc Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
    G M Clifford
    International Agency for Research on Cancer, 150, cours Albert Thomas, 69008 Lyon, France
    Br J Cancer 88:63-73. 2003
    ..A majority of ICC was associated with HPV16 or 18 in all regions, but approximately a quarter of all ICC cases were associated with one of 16 other HPV types, their distribution varying by region...
  17. pmc Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
    S Franceschi
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Br J Cancer 103:416-22. 2010
    ..It also led to marked increases in their life expectancy...
  18. pmc Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
    S Franceschi
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Br J Cancer 99:800-4. 2008
    ..06; 95% CI, 0.02-0.17). Thirty-three out of 52 (63.5%) KS cases among HAART users arose among PWHA who had stopped treatment or used HAART for less than 6 months...
  19. doi request reprint Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, Lyon, France
    Int J Epidemiol 37:536-46. 2008
    ..Smoking increases the risk of squamous-cell carcinoma of the cervix, but it is not clear whether smoking increases the risk of acquisition or persistence of human papillomavirus (HPV) infection...
  20. pmc Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study
    S Franceschi
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Br J Cancer 95:1598-602. 2006
    ..37; 95% CI: 1.03-5.43). No relationships between NHL risk and anti-HBc or HBsAg emerged. Coinfection with HIV and HCV or HBV did not increase NHL risk compared to HIV alone in the SHCS...
  21. ncbi request reprint Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea
    Gary M Clifford
    IARC, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 16:1874-9. 2007
    ..In contrast, HPV seropositivity among men was not associated with sexual behavior or the presence of HPV DNA. Seroprevalence correlates with genital HPV exposure in young women, but its meaning in young men is unclear...
  22. pmc HPV16 genetic variation and the development of cervical cancer worldwide
    I Cornet
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Br J Cancer 108:240-4. 2013
    ..Factors that favour a small proportion of HPV16 infections to progress to cancer are still poorly understood, but several studies have implicated a role of HPV16 genetic variation...
  23. pmc Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study
    M Dai
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Br J Cancer 95:96-101. 2006
    ..No significant difference in HPV positivity was observed by educational level, sexual habits, reproductive history or use of contraceptive methods in this rural low-income Chinese population...
  24. ncbi request reprint Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 15:326-33. 2006
    ..Our study showed an effect of both women's and their husbands' sexual behavior on HPV positivity. Furthermore, it suggests some differences in the pattern of the association between sexual behavior and different HPV types...
  25. ncbi request reprint HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas
    Aimee R Kreimer
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 115:329-32. 2005
    ....
  26. doi request reprint Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 19:2379-88. 2010
    ..Few human papillomavirus (HPV) seroprevalence studies have been carried out in women from low-resource countries...
  27. ncbi request reprint Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study
    Min Dai
    IARC, Lyon, France
    Cancer Res 64:468-71. 2004
    ..0; 95% confidence interval, 0.2-5.4). TP53 inactivation is a major mechanism of HPV-related carcinogenesis in the oral cavity and oropharynx. The role of HPV in cancers also containing TP53 mutations remains to be clarified...
  28. ncbi request reprint Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review
    Aimee R Kreimer
    International Agency for Research on Cancer, Lyon, France
    Cancer Epidemiol Biomarkers Prev 14:467-75. 2005
    ..Small sample size and publication bias complicate the assessment of the prevalence of HPV in head and neck sites beyond the oropharynx...
  29. doi request reprint Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis
    Hugo De Vuyst
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Int J Cancer 124:1626-36. 2009
    ..This proportion would be similar for the corresponding high-grade lesions of the vagina and anus, but higher for VIN2/3 (75%) than for vulvar carcinoma...
  30. ncbi request reprint Variations in the age-specific curves of human papillomavirus prevalence in women worldwide
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 119:2677-84. 2006
    ..These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences...
  31. ncbi request reprint Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
    Jerry Polesel
    Epidemiology and Biostatics Unit, Aviano Cancer Center, Aviano, Italy
    AIDS 22:301-6. 2008
    ..To assess the long-term effect of HAART on non-Hodgkin lymphoma (NHL) incidence in people with HIV (PHIV)...
  32. ncbi request reprint Fraction of cervical neoplasias due to human papillomavirus 16 and 18 in vaccine trials
    Silvia Franceschi
    Int J Cancer 122:719-20. 2008
  33. ncbi request reprint Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of China
    Min Dai
    Int J Cancer 121:1396-8. 2007
  34. ncbi request reprint Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation
    Rui fang Wu
    Department of Obstetrics and Gynecology, Shenzhen Hospital of Beijing University, Shenzhen, China
    Int J Cancer 121:1306-11. 2007
    ....
  35. ncbi request reprint Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update
    Jennifer S Smith
    Department of Epidemiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 7435, USA
    Int J Cancer 121:621-32. 2007
    ..Data on HPV-typed ICC and HSIL cases were particularly scarce from large regions of Africa and Central Asia...
  36. ncbi request reprint Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests
    Silvia Franceschi
    J Natl Cancer Inst 97:938-9; author reply 939-41. 2005
  37. ncbi request reprint Drug or symptom-induced depression in men treated with alpha 1-blockers for benign prostatic hyperplasia? A nested case-control study
    Gary M Clifford
    Department of Pharmacoepidemiology and Public Health, Postgraduate Medical School, University of Surrey, Guildford, UK
    Pharmacoepidemiol Drug Saf 11:55-61. 2002
    ..The aim was to assess the risk of depression with alpha 1-blockers independently of that associated with symptoms being treated and concurrent illness...
  38. ncbi request reprint Incidence, prevalence and management of lower urinary tract symptoms in men in the UK
    John Logie
    Department of Pharmacoepidemiology and Public Health, Postgraduate Medical School, University of Surrey, Guildford, UK
    BJU Int 95:557-62. 2005
    ..To describe the incidence, prevalence and management of lower urinary tract symptoms (LUTS), suggestive of benign prostatic hyperplasia, reported in UK general practice...
  39. ncbi request reprint No risk of drug-associated liver injury with alpha1-adrenoreceptor blocking agents in men with BPH: results from an observational study using the GPRD
    Gary M Clifford
    Department of Pharmacoepidemiology, Postgraduate Medical School, University of Surrey, Guildford, UK
    Pharmacoepidemiol Drug Saf 14:75-80. 2005
    ..To compare the risk of liver injury in men treated with alpha1-blockers against that in a similar non-exposed population...